{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Annual Securities Class Action Report Shows Life Sciences Firms Remain a Top Target for Claims",
    "url": "https://theindianlawyer.in/the-supreme-court-on-commercial-competition-and-the-limits-of-judicial-review-in-regulatory-decisions/?utm_source=rss&utm_medium=rss&utm_campaign=the-supreme-court-on-commercial-competition-and-the-limits-of-judicial-review-in-regulatory-decisions",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-FSY6FXTR",
        "url": "https://www.lexblog.com/lib/FSY6FXTR/"
    },
    "datePublished": "2022-02-18T10:06:00-05:00",
    "dateModified": "2022-02-22T07:11:32-05:00",
    "author": {
        "@type": "Person",
        "name": "Gregg Weiner, Adam Harris, Chloe Gordils"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Ropes & Gray"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Life Sciences Securities Litigation",
    "about": "Banking, Finance and Securities",
    "sourceUrl": "https://www.lifescienceslitigation.com/?p=2118",
    "sourceStability": "may-move"
}